Literature DB >> 21042774

RAGE ligands induce apoptotic cell death of pancreatic β-cells via oxidative stress.

Byung-Wan Lee1, Hee Young Chae, Soo Jin Kwon, So Youn Park, Jahei Ihm, Sung-Hee Ihm.   

Abstract

Activation of the receptor for advanced glycation endproducts (RAGE) by its ligands leads to cellular damage contributing to diabetic complications. It is not clearly known whether RAGE ligands influence pancreatic β-cells. In this study, we investigated the expression of RAGE in islet cells and the effect of RAGE ligands, S100b and HMG-1, on islet cells. RAGE was expressed in INS-1 cells and isolated rat and human islets at mRNA and protein levels. RAGE and its ligand, S100b, were detected on islet cells in 28-week-old diabetic OLETF rats. Both S100b and HMG-1 induced apoptotic cell death of INS-1 and islet cells. This INS-1 cell apoptosis was accompanied by increased intracellular oxidative stress and inhibited by antioxidants or a NADPH oxidase inhibitor. Our results showing S100b/RAGE expression on islets of diabetic rat model and RAGE ligands-induced islet cell apoptosis via NADPH oxidase-mediated ROS generation suggest that RAGE ligands-RAGE interaction may contribute not only to the development of diabetic complications but also to the progressive β-cell loss in type 2 diabetes by inducing oxidative stress.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21042774

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  23 in total

Review 1.  Glycation and insulin resistance: novel mechanisms and unique targets?

Authors:  Fei Song; Ann Marie Schmidt
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-08       Impact factor: 8.311

Review 2.  Receptor for AGE (RAGE): signaling mechanisms in the pathogenesis of diabetes and its complications.

Authors:  Ravichandran Ramasamy; Shi Fang Yan; Ann Marie Schmidt
Journal:  Ann N Y Acad Sci       Date:  2011-12       Impact factor: 5.691

Review 3.  HMGB1 in hormone-related cancer: a potential therapeutic target.

Authors:  Madhuwanti Srinivasan; Souresh Banerjee; Allison Palmer; Guoxing Zheng; Aoshuang Chen; Maarten C Bosland; André Kajdacsy-Balla; Ramaswamy Kalyanasundaram; Gnanasekar Munirathinam
Journal:  Horm Cancer       Date:  2014-04-10       Impact factor: 3.869

Review 4.  The receptor for advanced glycation endproducts is a mediator of toxicity by IAPP and other proteotoxic aggregates: Establishing and exploiting common ground for novel amyloidosis therapies.

Authors:  Andisheh Abedini; Julia Derk; Ann Marie Schmidt
Journal:  Protein Sci       Date:  2018-07       Impact factor: 6.725

5.  Alarmin high-mobility group B1 (HMGB1) is regulated in human adipocytes in insulin resistance and influences insulin secretion in β-cells.

Authors:  R Guzmán-Ruiz; F Ortega; A Rodríguez; R Vázquez-Martínez; A Díaz-Ruiz; S Garcia-Navarro; M Giralt; A Garcia-Rios; D Cobo-Padilla; F J Tinahones; J López-Miranda; F Villarroya; G Frühbeck; J M Fernández-Real; M M Malagón
Journal:  Int J Obes (Lond)       Date:  2014-02-28       Impact factor: 5.095

Review 6.  Receptor for Advanced Glycation End Products (RAGE) in Type 1 Diabetes Pathogenesis.

Authors:  Sherman S Leung; Josephine M Forbes; Danielle J Borg
Journal:  Curr Diab Rep       Date:  2016-10       Impact factor: 4.810

7.  RAGE binds preamyloid IAPP intermediates and mediates pancreatic β cell proteotoxicity.

Authors:  Andisheh Abedini; Ping Cao; Annette Plesner; Jinghua Zhang; Meilun He; Julia Derk; Sachi A Patil; Rosa Rosario; Jacqueline Lonier; Fei Song; Hyunwook Koh; Huilin Li; Daniel P Raleigh; Ann Marie Schmidt
Journal:  J Clin Invest       Date:  2018-01-16       Impact factor: 14.808

Review 8.  The use of the soluble receptor for advanced glycation-end products (sRAGE) as a potential biomarker of disease risk and adverse outcomes.

Authors:  Jorge D Erusalimsky
Journal:  Redox Biol       Date:  2021-03-29       Impact factor: 11.799

9.  RAGE and tobacco smoke: insights into modeling chronic obstructive pulmonary disease.

Authors:  Adam B Robinson; Jeffrey A Stogsdill; Joshua B Lewis; Tyler T Wood; Paul R Reynolds
Journal:  Front Physiol       Date:  2012-07-25       Impact factor: 4.566

10.  Is There Inflammatory Synergy in Type II Diabetes Mellitus and Alzheimer's Disease?

Authors:  Lih-Fen Lue; Cassandra Andrade; Marwan Sabbagh; Douglas Walker
Journal:  Int J Alzheimers Dis       Date:  2012-06-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.